Zopocianine

N/A

Report date: 2025/03/26 15:00:42

Base Information

Drug NameZopocianine
Drug Alias NameOTL-78OTL78
ClassificationDiagnostic agent (In vivo)Radiation-emitting products > Radioactive therapeutic agent
Mechanisms of ActionDiagnostic imaging enhancersProstate-Specific Membrane Antigen modulators
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPurdue UniversityEndocyte Inc
China Registration ClassN/A

Develop Information

Active CompaniesOn TargetPurdue UniversityNovartis Pharma Ag +[5] 
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A